Mkts

Inhibrx Biosciences, Inc.

NASDAQ: INBX
$90.45-1.29 (-1.41%)
As of Nov 10, 12:11 PM ET

Key statistics

Day range
89.9992.91
52-week range
57.30155.29
Today
Open91.03
Previous close90.45
Volume—
Valuation
Market cap1.35B
P/E ratio—
EPS (TTM)-8.88
Income & risk
Dividend / yield—
Beta3.21
Avg volume299.0K
Discussion

INBX News

Stories mentioning INBX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.001,3000.00100.000.00100.00
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development25,21725,34928,53522,26736,87733,36738,89367,632
Sales General & Admin
Total Operating Expenses30,92730,92333,81228,68942,90150,02846,797160,998
Operating Income (Loss)(30,927)(30,923)(33,812)(27,389)(42,901)(49,928)(46,797)(160,898)
Interest Income
Interest Expense
Other Expense(12.00)(39.00)(46.00)(246.00)(50.00)60.0041.0033.00
Pretax Income(33,441)(32,834)(35,256)(28,652)(43,311)(47,865)(43,864)1,858,013
Tax Provision0.000.000.002.000.000.000.002.00
Net Income (Loss)(33,441)(32,834)(35,256)(28,654)(43,311)(47,865)(43,864)1,858,011
Earnings Per Share (Basic)(2.15)(2.12)(2.28)(1.85)(2.80)(3.23)(2.84)127.10
Earnings Per Share (Diluted)(2.15)(2.12)(2.28)(1.85)(2.80)(3.19)(2.84)125.48
Weighted Average Shares Outstanding (Basic)15,58515,48715,47815,46815,46814,80215,46814,619
Weighted Average Shares Outstanding (Diluted)15,58515,48715,47815,46815,46814,98415,46814,807

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About INBX

Inhibrx Biosciences, Inc. (NASDAQ: INBX) is a stock listed on the Nasdaq Stock Market under the ticker symbol INBX. It last traded at $90.45 (Nov 10, 2026, 12:11 PM ET), down 1.4% on the day. That gives Inhibrx Biosciences a market capitalisation of $1.4B.

Over the past 52 weeks INBX has traded between $57.30 and $155.29.

For the quarter ended Mar 31, 2026 it reported a net loss of $33.4M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$33.4M—
Dec 31, 2025$0-$32.8M—
Sep 30, 2025$0-$35.3M—
Jun 30, 2025$1.3M-$28.7M-2204.2%

From Inhibrx Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…